Vascular Patches Market Assessment, By Material Type [Biologic Vascular Patches, Synthetic Vascular Patches], By Application [Carotid Endarterectomy, Open Repair of Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease, Profundaplasty, Others

Vascular Patches Market Assessment, By Material Type [Biologic Vascular Patches, Synthetic Vascular Patches], By Application [Carotid Endarterectomy, Open Repair of Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease, Profundaplasty, Others], By End-user [Hospitals, Ambulatory Surgical Centers, Trauma Care Centers], By Region, Opportunities and Forecast, 2017-2031F

Global vascular patches market is projected to witness a CAGR of 6.97% during the forecast period 2024-2031F, growing from USD 507.68 million in 2023 to USD 870.12 million in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

Vascular patches are used to treat aneurysms, arterial stenosis, and undesirable blood clots, in addition to reconstructing tissue or arteries in cardiovascular illnesses. Heart arteries (coronary arterial bypass), kidneys, legs (femoropopliteal bypass), and the abdominal aorta are the usual surgical sites. The increasing global prevalence of cardiovascular disorders is driving the growth of the vascular patches market. This aspect is reinforced by the rising global tobacco and smoking rates, which indicate a shift in stress levels and changing lifestyles. The market is driven by the aging population's increased vascular problems, the expansion of healthcare facilities, favorable reimbursement policies for treatments connected to these conditions, and the growing usage of biological patches. Vascular patches are also becoming more common because it is more expensive to create a healthcare infrastructure. Vascular patches are in high demand due to the high frequency of ischemic heart disease and stroke, both of which result in a significant number of hospital admissions. Furthermore, it is projected that the vascular patch market will grow a bit more slowly throughout the forecast period due to the decline in carotid endarterectomy surgeries.

For instance, owing to rising demand, Getinge AB expanded the production of premium vascular grafts in May 2022. The company's French facility has doubled its manufacturing capacity.

Growing Adoption of Regenerative Medicine to Fuel Market Growth

The growing use of regenerative medicine is the main factor propelling the market for vascular patches worldwide. Vascular patches are essential to the science of regenerative medicine, which is a game-changer in tissue repair and replacement. Regenerative medicine, which attempts to use the body's inherent healing capacity for tissue repair, is a major paradigm change in healthcare. This method shows promising results in treating several illnesses, such as heart problems, orthopedic injuries, and trauma-related tissue rebuilding. Vascular patches are essential to regenerative medicine since they act as biological scaffolds to direct cell development and differentiation. These patches are crucial in many different types of regenerative therapies because they foster natural tissue regeneration. Regenerative medicine has focused a lot of attention on the heart because of its restricted ability to regenerate. After myocardial infarctions, vascular patches have been effectively used in cardiac regeneration operations to help restore damaged heart tissues. Cardiovascular illnesses continue to be a major worldwide health concern; hence, regenerative medicine and vascular patches are anticipated to become more popular.

In addition, regenerative medicine shows results in treating orthopedic disorders such as injured ligaments and cartilage. Due to its reputation of supporting the tissue healing process, vascular patches are being used more frequently in orthopedic regenerative therapies. The need for these patches in orthopaedics is expected to increase as the population ages and musculoskeletal diseases become more common. Vascular patches have significantly improved skin regeneration and wound care. These patches encourage tissue regeneration by strengthening the body's inherent healing mechanisms, which may lessen problems and scarring. The market for vascular patches is expected to increase even more as regenerative medicine becomes more widely used in wound treatment. Regenerative medicine can shorten recovery times following surgery and gives hope to patients who may be suffering from any chronic illnesses. The goal of using vascular patches in surgical operations is to promote faster patient recovery, reduce problems, and improve tissue healing.

For instance, the S300X, which Lynxter revealed in November 2022, was hailed as a game-changing advancement in elastomer 3D printing technology.The strongest alternative available in the market right now for printing industrial and medical-grade silicones and polyurethanes is the S300X. Its integrated printed support technology has made it possible to print shapes that were previously unprintable. The S300X is a sturdy, compact, industrial tool that is perfect for creating customized masking parts for post-processing (painting, sanding, plasma treatment, etc.), as well as dampers, seals, orthoses that are approved for skin contact, and textiles with extra functionality.

In the same time frame, EPLUS 3D unveiled a state-of-the-art, nine-laser metal 3D printer. The first metal 3D printer company, EPLUS 3D, has formally announced the release of their large-format, multi-laser metal additive manufacturing system. The new machine, which has an in-built envelope of 1258 x 1258 x 1350 mm3 and NINE laser systems, will considerably boost the capacity for developing multi-meter metallic parts and attain the greatest levels of productivity and reliability. This marks the beginning of a new age in additive manufacturing. In terms of materials, the system can work with a variety of metal powders, including those based on titanium, aluminum, and nickel as well as stainless steel, maraging steel, chrome cobalt alloys, and other materials.

Advancements in Surgical Techniques Leading to Market Expansion

The market for vascular patches is expanding significantly on a global scale due to continuous improvements and developments in surgical methods. These developments have paved the way for novel applications of vascular patches in a variety of medical disciplines, increasing their use in surgical procedures across the globe. With its less invasive techniques, smaller incisions, and faster patient recoveries, minimally invasive surgery (MIS) has completely changed the way medicine is practiced. Vascular patches reduce patient discomfort and provide better tissue regeneration and healing in conjunction with MIS methods. Since vascular patches are compatible with MIS, surgeons and patients are favoring them more, which makes them appealing in the surgical environment. The goal of precision surgery is to get the best possible results by using sophisticated procedures and paying close attention to accuracy and detail. Vascular patches are essential for precision surgery because they improve tissue mending, lower surgical complexities and speed up the healing process. The assimilation of these devices into surgical operations in diverse medical disciplines leads to improved surgical results and faster patient recuperation.

Vascular patches are now a vital tool in cardiovascular surgery for healing injured heart tissues and speeding the recovery process. The growing need for vascular patches further solidifies their significance in cardiovascular treatments as surgical techniques in cardiology, particularly the adoption of minimally invasive approaches, advance. Vascular patches are useful in orthopedic surgery for treatments including joint replacement, arthroscopy, and fracture repair because they promote tissue regeneration and recovery. Vascular patches are becoming a more important tool for optimizing surgical techniques and improving patient outcomes as orthopedic surgery advances. These patches are essential for tissue healing and natural-looking outcomes in aesthetic and reconstructive surgery, especially in cases like breast and facial reconstruction. The need for vascular patches in these treatments is further driven by the ongoing advancements in aesthetic surgery techniques. Vascular patches facilitate tissue restoration by creating an environment that is favorable for the process. The market is growing because surgeons from various disciplines are incorporating vascular patches into surgical procedures at an increasing rate.

For instance, Vivasure Medical Ltd. led a series D funding round in May 2022 in which the company closed the first tranche of USD 22 million. With this funding, the business hopes to gain regulatory approval in the United States and Europe for its portfolio of large-bore, patch-based, entirely absorbable percutaneous vessel closure devices used in transcatheter endovascular and cardiovascular surgeries.

Increasing Dominance of Aortic Aneurysm Positively Impacts the Market

Over the course of the forecast period, the vascular patches market is anticipated to have significant growth in the aortic aneurysm sector. The growing number of elderly people, the increasing burden of vascular illnesses like atherosclerosis, and the rising demand for minimally invasive procedures are the main growth drivers in this segment. Aortic aneurysms are balloon-like bulges in the aorta, the main artery that travels through the chest and body to carry blood from the heart. An ascending aortic pseudoaneurysm is an uncommon but potentially deadly complication following heart surgery that may burst. Patch repair is frequently used in place of replacing a tube graft for treating a tiny, localized saccular pseudoaneurysm of the aorta. One of the main drivers responsible for expanding this market is the rise in incidences of atherosclerosis and aortic aneurysms. For example, data released in April 2022 by National Health Services (NHS) United Kingdom indicates that around 1,542 cases of aneurysms were documented in the United Kingdom in 2021. Furthermore, vascular disorders are becoming more common in the aging population, which is also causing the segment to rise. Due to the growing elderly population, the market is expected to grow rapidly over the forecast period.

North America to Dominate the Vascular Patches Market

Over the course of the forecast period, North America is anticipated to have a sizable share of the global vascular patch market due to factors including the rising prevalence of vascular disorders. Furthermore, the United States is experiencing an increase in healthcare expenditure, which opens new avenues for the development of improved vascular patches and makes them more widely available, spurring market expansion. According to the organization of economic cooperation and development (OECD) data, healthcare spending in the United States in June 2022 was 17.8% of the nation's overall GDP in 2021. It is anticipated that the region's growing funding for atherosclerosis will quicken the development of vascular patches and sharpen the company's focus on creating cutting-edge products, which will spur market expansion. For example, May 2022 data from the National Institute of Health (NIH) indicates that approximately USD 413 million was granted for atherosclerosis in 2021. Approximately USD 430 million was allocated in 2022 for research and studies related to the condition, and it was anticipated that this funding would increase to USD 432 million by 2023. Additionally, the increasing incidence of cardiovascular diseases and accompanying conditions like diabetes raise the risk of stroke, cerebrovascular disease, and other conditions that need surgery, supporting the market's expansion. For example, according to estimates made by the International Diabetes Federation (IDF) in 2022, 14.1 million people in Mexico had diabetes in 2021 and by 2030, this figure is expected to rise to 17 million, and by 2045, it is expected to reach 21.1 million. The same source states that approximately 32 million Americans and 2.9 million Canadians had diabetes in 2021, and this figure is expected to rise to 36.2 million and 3.4 million, respectively, by 2045. Thus, there may be a greater need for cardiac procedures because of the rising incidences of diabetes-related cardiovascular problems. This is expected to drive the demand for vascular patches, supporting market expansion.

Future Market Scenario (2024-2031F)

One of the main factors contributing to the anticipated growth of the vascular patches market is the increasing prevalence of chronic diseases and vascular disorders. Not only this, but the rising population and sedentary lifestyles are also factors that will always propel market growth in the future. Given that technology is advancing, cutting-edge technology can also be expected in this area also. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, the Teijin Limited, Fukui Tateami Co., Ltd., and Osaka Medical and Pharmaceutical University consortium recently announced that Teijin Medical Technologies Co., Ltd., a Teijin Group company, will begin manufacturing and distributing a novel surgical patch on June 12, 2024. The patch will be marketed under the brand name SYNFOLIUM.

Key Players Landscape and Outlook

Several companies, such as Baxter International, Inc., LeMaitre Vascular, Inc., W. L. Gore & Associates, Inc., Getinge AB, B. Braun Medical Ltd., Edwards Lifesciences Corporation, Becton, Dickinson and Company, Terumo Corporation, Artivion, Inc., and Labcor Laboratórios, etc., are expanding their businesses by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launch of newly developed vascular patches, to help researchers to strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.

In 2022, Labcor Laboratórios Research Centre received ISO 9001 certification for its technical development of experimental cardiovascular and vascular operations.

Medical technology company, Haemonetics Corporation announced on September 12, 2022, that it had obtained CE mark certification for its VASCADE venous vascular closure and VASCADE MVP vascular closure systems.